サインイン

Sangya Agarwal

Center for Cellular Immunotherapies,
Perelman School of Medicine,
Parker Institute for Cancer Immunotherapy,
Center for Cellular Immunotherapies, Perelman School of Medicine

University of Pennsylvania

BIOGRAPHY

Sangya Agarwal has not added Biography.

If you are Sangya Agarwal and would like to personalize this page please email our Author Liaison for assistance.

PUBLICATIONS

Novel prostate cancer immunotherapy with a DNA-encoded anti-prostate-specific membrane antigen monoclonal antibody.

Cancer immunology, immunotherapy : CII Dec, 2017 | Pubmed ID: 28819703

Synthetic nucleic acid antibody prophylaxis confers rapid and durable protective immunity against Zika virus challenge.

Human vaccines & immunotherapeutics 04, 2020 | Pubmed ID: 31799896

Impaired Death Receptor Signaling in Leukemia Causes Antigen-Independent Resistance by Inducing CAR T-cell Dysfunction.

Cancer discovery 04, 2020 | Pubmed ID: 32001516

Harnessing CAR T-cell Insights to Develop Treatments for Hyperinflammatory Responses in Patients with COVID-19.

Cancer discovery 06, 2020 | Pubmed ID: 32303509

LFA-1 signals to promote actin polymerization and upstream migration in T cells.

Journal of cell science Sep, 2020 | Pubmed ID: 32907931

INSTITUTIONS

University of Pennsylvania

JOVE ARTICLES

Production of Human CRISPR-Engineered CAR-T Cells

Sangya Agarwal^*,1,2,

Nils Wellhausen^*,1,2,

Bruce L. Levine^1,2,

Carl H. June^1,2

¹Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania,

²Parker Institute for Cancer Immunotherapy, University of Pennsylvania

Immunology and Infection

個人情報保護方針

利用規約

一般データ保護規則

お問い合わせ

図書館への推薦

JoVE ニュースレター

研究

JoVE Journal
メソッドコレクション
JoVE Encyclopedia of Experiments
アーカイブ

教育

JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
教員向けリソースセンター
教員用サイト

著者

概要
出版プロセス
編集委員会
スコープと指針
査読
よくある質問
お申し込み

図書館員

概要
お客様の声
定期購読
アクセス
リソース
図書館諮問委員会
よくある質問

JoVEについて

概要
経営陣
ブログ

Sangya Agarwal

.css-o250i3{font-size:18px;font-family:Open Sans,sans-serif;line-height:21.6px;}Center for Cellular Immunotherapies,Perelman School of Medicine,Parker Institute for Cancer Immunotherapy,Center for Cellular Immunotherapies, Perelman School of Medicine

University of Pennsylvania

Production of Human CRISPR-Engineered CAR-T Cells

Center for Cellular Immunotherapies,
Perelman School of Medicine,
Parker Institute for Cancer Immunotherapy,
Center for Cellular Immunotherapies, Perelman School of Medicine